MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock under...
$6,362K
Proceeds from issuance of
common stock from the...
$4,831K
Net cash provided by
financing activities
$11,193K
Net increase
(decrease) in cash, cash...
-$47,222K
Canceled cashflow
$11,193K
Stock-based compensation
expense
$47,603K
Accounts payable
$6,648K
Depreciation and
amortization
$6,390K
Deferred revenue
$3,306K
Other liabilities
$1,868K
Accrued compensation
$1,590K
Inventory write-down
$565K
Provision for credit
losses
$219K
(gain) loss on foreign
currency transactions
-$157K
Accrued interest
expense
$142K
Net cash used in
operating activities
-$48,985K
Canceled cashflow
$68,488K
Net cash used in
investing activities
-$9,356K
Effect of exchange
rates on cash, cash...
-$74K
Net loss
-$95,572K
Inventory
$14,498K
Other assets
$2,895K
Loan facility
liability
-$2,000K
Prepaid expenses and
other current assets
$1,102K
Accounts receivable, net
$898K
Non-cash lease
adjustment
$508K
Purchases of property and
equipment
$9,356K
Back
Back
Cash Flow
source: myfinsight.com
PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics Corp (PRCT)